By Rick Archer ( April 25, 2022, 7:52 PM EDT) -- The U.S. Trustee's Office on Monday urged a Delaware bankruptcy judge to reject generic pharmaceutical maker Teligent Inc.'s Chapter 11 plan disclosures, saying the statement provides a "baffling" explanation of impermissible, involuntary third-party liability releases....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.